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HYDERABAD: A team of researchers from the Indian Institute of Technology (IIT)- Hyderabad 
have developed an effective combination therapy for cancer treatment, which combines the 
usually-used technique of chemotherapy with photothermal therapy (PTT).  
 
The motive behind developing a combination of therapies was to come out with a technique to 
treat cancer with minimal or no side-effects at all, as the current approaches including surgery, 
chemotherapy and radiotherapy have adverse side-effects, said the researchers. 
 
The treatment has been developed by researchers from the department of biomedical engineering, 
IIT-Hyderabad. For the combination therapy, the researchers used a naturally-derived anti-cancer 
agent called ‘CfAC’ that is extracted from the plant Anthocephalous Cadamba, which has shown 
efficacy in destroying cancer cells. 
 
Dr Aravind Kumar Rengan, assistant professor,  Department of Biomedical Engineering, who 
headed the research said, ‘’In photothermal therapy, a material that converts light to heat is 
specifically sent to the tumour location, and when irradiated, causes ablation or destruction of the 
host cancer cells. IR780 is one such dye that absorbs near-infrared light and generates reactive 
oxygen species that kills the host cell. This dye is loaded onto a suitable carrier material and 
targeted at the cancer tissues,” he added. 
 
The researchers used liposomes - lipid nanoparticles a hundred thousand times smaller than the 
width of a single human hair - as the carriers for the IR780 because of their low toxicity, flexibility, 
biocompatibility, biodegradability and non-immunogenicity.  
 
The team loaded liposomes not only with IR780 dye but also with CfAC. 
 
These liposomes were tested against human breast cancer cells that were introduced into mice 
groups.  
 
“We have demonstrated the synergistic and enhanced therapeutic benefits of combinational 
therapy against breast cancer with minimal/no adverse effects using biocompatible and 
biodegradable nanomaterials,” Dr Aravind said. 
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